Autor: |
Mark P. Lythgoe, Benjamin H. Mullish, Adam E. Frampton, Jonathan Krell |
Přispěvatelé: |
Imperial College Healthcare NHS Trust- BRC Funding, 4D Pharma Plc, Ovarian Cancer Action |
Rok vydání: |
2022 |
Předmět: |
|
Zdroj: |
Trends in Microbiology. 30:1131-1134 |
ISSN: |
0966-842X |
Popis: |
Recognition of the microbiome (and 'polymorphic microbes' within them) as a new emerging hallmark of cancer reflects a wide body of rapidly evolving research. Microbes may be directly carcinogenic, impact host immune responses to promote malignancy, and may be key effectors in determining the efficacy of anticancer therapy. Manipulation of the microbiome is showing promise as an opportunity to influence cancer outcomes. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|